Found: 10
Select item for more details and to access through your institution.
Longitudinal increase in depressive symptoms in relation to neurodegeneration in clinically normal older adults: Findings from the Harvard Aging Brain Study: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047321
- By:
- Publication type:
- Article
Are amyloid and tau synergistic? How to interpret an amyloid/tau interaction on cognitive decline in clinically normal adults: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044310
- By:
- Publication type:
- Article
Associations of peak width of skeletonized mean diffusivity with cardiovascular disease risk and cognitive decline in clinically normal older adults: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043812
- By:
- Publication type:
- Article
The dynamic interplay between longitudinal subjective and objective cognitive decline along the early AD spectrum in the Harvard Aging Brain Study: Featured research and focused topic sessions: The transitional stage 2 of Alzheimer's disease — Clinical features, biomarkers and longitudinal course
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040260
- By:
- Publication type:
- Article
Repeated memory‐based assessments: Implications for clinical trials and practice: Using digital technology to drive clinical innovation in brain‐behavior relationships: A new era in neuropsychology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038143
- By:
- Publication type:
- Article
Defining the ATN framework using longitudinal biomarker trajectories reveals an emerging amyloid accumulation group.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068001
- By:
- Publication type:
- Article
Longitudinal increase in depressive symptoms in relation to neurodegeneration in clinically normal older adults: Findings from the Harvard Aging Brain Study: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.047321
- By:
- Publication type:
- Article
Are amyloid and tau synergistic? How to interpret an amyloid/tau interaction on cognitive decline in clinically normal adults: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.044310
- By:
- Publication type:
- Article
The dynamic interplay between longitudinal subjective and objective cognitive decline along the early AD spectrum in the Harvard Aging Brain Study: Featured research and focused topic sessions: The transitional stage 2 of Alzheimer's disease — Clinical features, biomarkers and longitudinal course
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.040260
- By:
- Publication type:
- Article
Repeated memory‐based assessments: Implications for clinical trials and practice: Using digital technology to drive clinical innovation in brain‐behavior relationships: A new era in neuropsychology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.038143
- By:
- Publication type:
- Article